Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

China Medical System Holdings Ltd (0867)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.22 +0.02    +0.28%
04:08:20 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG211081248 
  • Volume: 7,090,000
  • Bid/Ask: 7.22 / 7.23
  • Day's Range: 7.15 - 7.37
China Medical System 7.22 +0.02 +0.28%

China Medical System Holdings Ltd Company Profile

 
Get an in-depth profile of China Medical System Holdings Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

5701

Equity Type

ORD

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis. The company also offers Salofalk for treating Ulcerative Colitis and Crohn’s disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; ILUMETRI, a tildrakizumab injection to treat moderate-tosevere plaque psoriasis; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. In addition, it provides Aethoxysklerol for sclerotherapy of different varicose veins; Heling Soothing product for skin soothing; Vmonalisa for mid to deep dermal implantation; Neauvia Hyaluronic Acid series; EyeOP1 to treat glaucoma; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; MOVICOL for treating chronic constipation and faecal impaction; and MeteoSpasmyl to treat gastrointestinal flatulence and pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.

Contact Information

Address Island Place Tower Unit 2106
21st Floor 510 King’s Road North Point,
Hong Kong
Phone 852 2369 7678
Fax 852 2389 1320

Top Executives

Name Age Since Title
Chi Keung Wu 64 2010 Independent Non-Executive Director
Chong Shun Leung 56 2017 Independent Non-Executive Director
Laura Ying Luo 56 2020 Independent Non-Executive Director
Ching Simon Fung 52 2021 Independent Non-Executive Director
Kong Lam 58 2006 Founder, Chairman, CEO & President
Yanling Chen 54 2006 CFO, VP & Executive Director
Hongbing Chen 57 2006 COO, VP, Director of Sales & Marketing and Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0867 Comments

Write your thoughts about China Medical System Holdings Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JAME Megueni
VRAQ Mar 18, 2021 10:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Morgan Stanley Raises CMS TP to $22; Rated ***Overweight***
JAME Megueni
VRAQ Mar 17, 2021 9:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Citi Upgrades CMS to ***Buy*** with TP Hiked to $26
JAME Megueni
VRAQ Jan 25, 2021 9:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
*M Stanley Revises up CMS (00867) TP to $14.3; Rated Overweight
Anesh Patel
Anesh Patel Dec 08, 2020 12:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is this share so undervalued? What are the risks? I cant seem to find any!
Mladen Adamović
Mladen Adamović Dec 08, 2020 12:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
While I don't know the answer to your question, I have recently invested in this stock, some warnings is that recently volumes are low and spread could become high, so if someone is investing into this go only with Limit order.  I thought that pharmaceuticals would perform better in China in the future so end up in this stock. I don't know much about the company (it's more a holding company, which means a parent of some). Pharmaceuticals companies generally do not have current great stock performances (i.e. Pfizer,) , unless they are new and developing (i.e. BioNTech).  As I have put quite some of this portfolio, I'm hoping this work work better. So far I'm down 1.1% in two days.
chaewon kim
chaewon kim Apr 29, 2019 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very under valued. second going in after price drop.
chaewon kim
chaewon kim Apr 29, 2019 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very under valued. second going in after price drop.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email